Adela: Funding, Investors & Team (Sep 2026)
Adela specializes in creating groundbreaking and easily accessible technologies that aim to identify cancer and other diseases with high rates of illness and death. Through a simple blood test, Adela's advanced technology, known as the genome-wide methylome enrichment platform, efficiently collects data from the entire methylome. This innovative system accurately differentiates between the most informative (methylated) parts of the genome and non-informative sections, giving priority to sequencing those valuable regions.
Adela has raised $81.0M across 3 funding rounds on record, the most recent an undisclosed round of $5.0M announced in Apr 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Adela Company Profile and Key Stats
Latest funding round on record: Apr 2026.
Adela Funding Rounds
Adela raised $28.0M in an undisclosed round announced in Aug 2023.
1 month later, a Series A of $48.0M was announced in Sep 2023.
2.6 years later, an undisclosed round of $5.0M was announced in Apr 2026.
Adela Founders and Leadership Team
Contact details for the Adela team: 1 of 2 have an email address on file.
Start 14-day free trial →Adela Funding Compared to Other Biotechnology Startups
Adela's latest round of $5.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Adela in Biotechnology and Foster City
Companies Similar to Adela
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Adela Funding FAQs
What does Adela do?
Adela specializes in creating groundbreaking and easily accessible technologies that aim to identify cancer and other diseases with high rates of illness and death. Through a simple blood test, Adela's advanced technology, known as the genome-wide methylome enrichment platform, efficiently collects data from the entire methylome. This innovative system accurately differentiates between the most informative (methylated) parts of the genome and non-informative sections, giving priority to sequencing those valuable regions.
How much funding has Adela raised?
Adela has raised $81.0M across 3 rounds on record. The most recent is an undisclosed round of $5.0M announced in Apr 2026.
When did Adela last raise funding?
Adela's most recent funding round on record is an undisclosed round of $5.0M, announced in Apr 2026.
Who founded Adela?
FundedIQ lists Lisa Alderson (Founder) at Adela.
Who is the CEO of Adela?
Scott Bratman is listed as CEO at Adela.
Where is Adela headquartered?
Adela is based in Foster City, California, United States.
How many employees does Adela have?
Adela is in the 51-100 employee band.
How does Adela's funding compare to other Biotechnology startups?
Adela's latest round of $5.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Adela Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Adela is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.